Related Experiment Video
Updated: Jun 19, 2026

06:17
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
THE LS-ANTIGEN OF VACCINIA : II. ISOLATION OF A SINGLE SUBSTANCE CONTAINING BOTH L- AND S-ACTIVITY
1Laboratories and the Hospital of The Rockefeller Institute for Medical Research.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Researchers identified a single LS-antigen in vaccinia virus filtrates. This protein molecule possesses two distinct antigenic parts, L and S, crucial for understanding vaccinia virus immunology.
Area of Science:
- Virology
- Immunology
- Biochemistry
Background:
- Vaccinia virus filtrates contain soluble substances with antigenic properties.
- Previous studies indicated complexity in vaccinia virus soluble antigens.
Purpose of the Study:
- To isolate and characterize the components responsible for L- and S-activity in vaccinia virus filtrates.
- To elucidate the antigenic structure of vaccinia virus soluble components.
Main Methods:
- Electrophoresis was used to separate components.
- Solubility changes with pH were exploited for purification.
- Serological tests (precipitation, inhibition) and ultracentrifugation were employed for characterization.
Main Results:
- Four distinct components were identified in vaccinia virus filtrate.
- A single component, LS-antigen, was found to possess both L- and S-activity.
- LS-antigen is a homogeneous protein molecule with two distinct antigenic sites (L and S).
- Differential heating and alkali treatment selectively modified the L or S portions of the LS-antigen, affecting precipitation but not necessarily binding.
Conclusions:
- Vaccinia virus LS-antigen is a single protein molecule with dual antigenic specificities (L and S).
- The L and S antigenic determinants are distinct yet associated within the same molecule.
- Understanding LS-antigen structure provides insights into vaccinia virus antigenicity and immune response.
Related Concept Videos
Smallpox
Smallpox is a severe contagious disease caused by the Variola major virus, a double-stranded DNA member of the Poxviridae family.Variola major transmission occurs primarily via inhalation of virus-laden droplets or direct contact with infectious scabs. The incubation period averages approximately seven days, although it may range from 7 to 17 days depending on the inoculum and host factors.Clinically, the prodromal phase is marked by an abrupt onset of high fever, malaise, headache, and myalgia.
Vaccinations
Overview
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

